Repurposing tamibarotene to reprogram cardiac fibroblasts improves diastolic function and exercise capacity in chronic HFpEF

28 August 2026 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Heart failure and HFpEF mechanisms Drugs, Drug Targets ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology